NCT06962137
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06962137
Title Phase II RAINSPOT: Zolbetuximab-Paclitaxel-Ramucirumab for CLDN18.2 Positive Gastro-esophageal Cancer (RAINSPOT)
Acronym RAINSPOT
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Universitaire Ziekenhuizen KU Leuven
Indications
Therapies
Age Groups: senior | adult
Covered Countries BEL


No variant requirements are available.